🧬 Bryan Dechairo - Sherlock Biosciences - Part 2 | Transitioning From a Small Startup to Pfizer | Big Data's Role in Modern Genetics | Building & Leading Dynamic Teams | The Evolution of Personalized Medicine

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 2 of 3. 

My guest for this week’s episode is Bryan Dechairo, President, CEO, and Director at Sherlock Biosciences, an innovative biotech company that is enabling the democratization and decentralization of diagnostic testing to personalize healthcare and make an impact on global health.

Before Sherlock, and most recently, Bryan was Executive VP at Myriad Genetics and CSO and CMO at Assurex Health. His extensive career spans over two decades and also includes prominent positions at Medco Health, Pfizer, Oxagen, Sequana Therapeutics, and Roche. Bryan's vast experience working at both startups and Fortune 500 companies gives him unique insights that any entrepreneur can benefit from. 

Join us this week and hear about:

Please enjoy my conversation with Bryan Dechairo.

Find Our Guest, Bryan Dechairo, at these links: 

00:28 Intro and episode overview

01:53 Bryan’s transition from academia and a small startup to Pfizer

02:37 The role and impact of big data in Bryan's career

05:20 Building a team and fostering the right environment for employees

06:56 Supporting team growth, helping individual contributors succeed

09:37 Reflections on career development, key learning points from working at startups

12:08 Adjusting to Pfizer, finding the right fit, and dealing with anxiety

15:07 Discussing strategic decision-making and incorporating new technologies

16:23 Managing different teams and the matrix-based organizational structure

19:49 Start with the Problem Statement: identify a need, then create a solution

24:40 Transitioning from Pfizer to Medco Health and learning about personalized medicine

27:17 Evolving role of pharmacy benefit managers in healthcare and diagnostics reimbursement

30:38 Closing thoughts on the healthcare industry and advancements in Diagnostics

33:10 Outro

LinkedIn: https://www.linkedin.com/company/excedr/ 

Youtube: https://www.youtube.com/@excedr 

Instagram: https://www.instagram.com/excedr_inc 

Twitter: https://twitter.com/ExcedrInc 

Facebook: https://www.facebook.com/excedr 

TikTok: https://www.tiktok.com/@excedr 

Podcast Website: https://www.thebiotechstartupspodcast.com/

Oxagen https://www.crunchbase.com/organization/oxagen

Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support

Big Data in Healthcare https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733917/

Biotech & Big Pharma Partnerships https://www.excedr.com/blog/how-biotech-partnerships-support-research

Therapeutics https://www.nature.com/subjects/therapeutics

Personalized Medicine https://www.genome.gov/genetics-glossary/Personalized-Medicine

Pfizer https://www.pfizer.com/

Molecular Medicine https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/molecular-medicine

Genetics, Proteomics, & Metabolomics https://www.isaaa.org/resources/publications/pocketk/15/default.asp

Matrix Organization https://asana.com/resources/matrix-organization

Pharmacy Benefit Managers https://en.wikipedia.org/wiki/Pharmacy_benefit_management

Jeff Kindler https://www.linkedin.com/in/jeffrey-b-kindler-a304b136/

Rob Epstein https://www.linkedin.com/in/epstein-robert-2937979/

Julie Garlikov https://www.linkedin.com/in/juliegarlikov/

The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.